ZiO Health Market Research Report
Company Overview
- Name: ZiO Health Ltd
- Mission: To democratize medical testing and health data, making it more accessible for individuals to make meaningful lifestyle changes and improve their health.
- Founded: 2016
- Founders: Dr. Neel Patel and Dr. Shaolin Liang
- Headquarters: London, England
- Additional Locations: Offices in Shenzhen, Guangdong, China, and San Francisco, California, USA
- Number of Employees: 11–50 employees
- Industry: Medical Equipment Manufacturing
- Revenue: No information is available
- Key People:
- Neel Patel, Founder & CEO
- Shaolin Liang, PhD, Scientific Founder
- Notable Aspects: Known for its proprietary biosensor technology and AI-driven therapeutic drug monitoring devices. The company focuses on optimizing drug treatment outcomes and reducing the waiting time for blood test results.
Products
Biosensor Technology
- Description: ZiO Health's proprietary technology facilitates laboratory-grade testing at point-of-care.
- Key Features:
- Pocket-sized device
- AI-based diagnostics
- Single-point and continuous monitoring
- Low-cost platform
Therapeutic Drug Monitoring
- Description: AI-driven handheld device for monitoring therapeutic drugs.
- Key Features:
- Provides immediate drug concentration data in the blood
- AI-guided dosing model for precision and personalized dosing
- Aimed at increasing drug treatment efficacy and minimizing toxicity
- Proven cost reduction and enhanced patient care
- Device calibrates both free and total vancomycin levels more accurately
Elosia Home Health Hub
- Description: Enhances remote consultations by providing molecular-level testing technology access from homes.
Recent Developments
- Recent Developments:
- Collaboration with Kidney Research UK to improve renal healthcare outcomes with ZiO Health's diagnostics technology.
- Engagements with CPI to enhance biosensor technology usability.
- New Products Launched:
- No specific new products have been mentioned in recent developments.
- New Features Added:
- Integration improvements in the Therapeutic Drug Monitoring device to align with clinical workflows.
- Partnerships:
- Participated in the Global Business Innovation Programme focusing on medtech, supported by Innovate UK and designed to explore opportunities in Singapore.
- Engaged in Grow London Global initiatives for life sciences trade missions to advance in markets like Japan and China.
Conclusion
ZiO Health continues to push the boundaries of health technology through strategic partnerships and innovative developments in therapeutic drug monitoring and biosensor technology. Their mission of making precise medical diagnostics readily accessible at the point-of-care positions them as a significant player in the medtech landscape. As they expand their global footprint, collaborations with key health organizations and trade missions highlight their momentum in advancing precision medicine.
(Note: For fields with no information available from the data, "No information is available" is explicitly mentioned.)